Author:
Chebotareva N V,Guliaev S V,Androsova T V,Milivanova L U
Abstract
The present review is focused on risk factors of chronic kidney disease in rheumatoid arthritis (RA). According to recent data, the chronic kidney disease (CKD) in RA patients is more often than at patients without RA. It is closely associated with risk of cardiovascular disease and high mortality. Besides of general population risk factors of CKD, the activity of the disease is independent predictors of reduction in glomerular filtration rate less than 60 ml/min/1.73 m2. In the review, histopathological variants and mechanisms of CKD on basis of international experience are also considered. Suppression of inflammation by basic therapy of RA and biological therapy have changed outcomes RA, prevalence, and structure of kidney involvement in recent years.
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,History,Family Practice
Reference58 articles.
1. Waldburger J.M, Firestein G.S. Rheumatoid arthritis: B. Epidemiology, pathology, and pathogenesis. In: Klippel J.H (ed). Primeron the Rheumatic Diseases, 13th edn. New York, NY: Springer, 2008:122-132.
2. Carmona L, Cross M, Betal W. Rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2010;24:733-74.
3. Etiology and pathogenesis of rheumatoid arthritis. In: Firestein G.S, Kelley W.N (eds). Kelley’s Textbook of Rheumatology, 8th edn. Philadelphia, PA: Saunders/Elsevier, 2009:1035-86.
4. Насонов Е.Л. Фармакотерапия ревматоидного артрита: новая стратегия, новые мишени. Научно - практическая ревматология. 2017;55(4):409-19. https://doi.org/10.14412/1995-4484-2017-409-419
5. Listing J, Kekow J, Manger B, et al. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab. Ann Rheum Dis. 2015;74:415-21.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献